We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | -1.19 | -9.01515151515 | 13.2 | 13.42 | 8.43 | 47505 | 10.73041876 | CS |
52 | 7.9625 | 196.726374305 | 4.0475 | 24 | 2.66 | 2865336 | 10.8580441 | CS |
156 | -189.49 | -94.0397022333 | 201.5 | 217 | 2.66 | 1270005 | 22.86079017 | CS |
260 | -171.24 | -93.446111869 | 183.25 | 284.5 | 2.66 | 786279 | 38.25883834 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions